Matthew F. Dunn

机构：The University of Sydney, Pfizer (United States)

发表论文 8 篇 · 总被引 368 次 · h-index 7

代表论文

Synthesis and Evaluation of Sphinganine Analogues of KRN7000 and OCH (2005 · The Journal of Organic Chemistry · 被引 85)
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate (2014 · ACS Medicinal Chemistry Letters · 被引 71)
Nanostructured Hydroxyapatite Coatings for Improved Adhesion and Corrosion Resistance for Medical Implants (2001 · MRS Proceedings · 被引 63)
Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation (2008 · Bioorganic & Medicinal Chemistry Letters · 被引 53)
Spirolactam-Based Acetyl-CoA Carboxylase Inhibitors: Toward Improved Metabolic Stability of a Chromanone Lead Structure (2013 · Journal of Medicinal Chemistry · 被引 47)
Synthesis of Spiropiperidine Lactam Acetyl-CoA Carboxylase Inhibitors (2012 · The Journal of Organic Chemistry · 被引 33)